Elevated plasma levels of the liver protein follistatin may predict incident chronic kidney disease and other adverse outcomes, independent of diabetes, based on 23-year follow-up of a Swedish cohort.
Elevated plasma prostasin levels may be a potential biomarker of diabetes and cancer mortality, according to a prospective, population-based study out of Sweden.